Isabelle Ackermann

Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial

A. Mtoro, B. Ogutu, J. Lusingu, 2016, The Lancet. Infectious Diseases.

Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial

A. Mtoro, B. Ogutu, J. Lusingu, 2016, The Lancet. Infectious Diseases.

Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial

A. Mtoro, B. Ogutu, J. Lusingu, 2016, Lancet. Infectious Diseases (Print).

Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial

A. Mtoro, B. Ogutu, J. Lusingu, 2016, The Lancet. Infectious diseases.